Fauna Bio CTO Linda Goodman presented at MLxBio on our enhanced ML approach to target and therapeutics discovery using our proprietary disease resistance datasets and integration with human genomics.

Oct 20

Written By Kacey Haptonstall, Translational Operations Manager

Kacey Haptonstall, Translational Operations Manager https://www.linkedin.com/in/kacey-haptonstall-15385552/

Fauna Bio CEO, Ashley Zehnder, Featured on the “Talking Precision Medicine” Podcast by Genialis.

Fauna Bio welcomes intern Jessica Peers